“Porem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.”
Minh completed his PhD in Chemistry at UCSF under the supervision of Dr. Ian Seiple. He developed a total synthesis platform tailored for the complex sesquiterpene trichothecene family of natural products. Furthermore, in collaboration with the James Fraser lab, Minh elucidated the molecular interactions between verrucarol and diacetylverrucarol with the human cytosolic ribosome's 50S subunit, providing high-resolution data of 2.7 Å. These findings provide insights for structural modifications, facilitating deeper investigations into trichothecene's toxicity and molecular mechanisms.
During his PhD, he also played various roles at Lyterian Therapeutics, Nucleate Genesis, and MPM Capital, collaborating closely with industry leaders, contributing to competitive landscape analysis, library designs for high throughput screening, as well as leading diligent processes, formulating innovative company concepts, and gaining insights into licensing, IP strategy, and clinical indication strategy development.
At General Proximity, Minh is currently a scientist working with the Platform and Chemistry teams to develop new classes of proximity inducing therapeutics, as well as spearheading the development of a next-gen extremely high-throughput proximity screening engine. He is excited to leverage his skills and experiences to drive meaningful contributions in therapeutic sciences.
